These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2960150)

  • 1. Effects of prostacyclin on cardiopulmonary bypass-mediated lung damage using extravascular lung water measurements.
    Starling MB; Neutze JM
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1091-3. PubMed ID: 2960150
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of prostaglandin I2 on lung vascular permeability after endotoxin in dogs (author's transl)].
    Ikeda T
    Fukuoka Igaku Zasshi; 1981 Mar; 72(3):71-81. PubMed ID: 7021383
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels.
    Fortier S; DeMaria RG; Lamarche Y; Malo O; Denault A; Desjardins F; Carrier M; Perrault LP
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):109-16. PubMed ID: 15224029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of prostacyclin (PGI2) on increased pulmonary microvascular permeability due to endotoxin].
    Yamada Y; Akune T; Higuchi M; Chinzei T; Morita S; Toyooka H; Inada Y
    Masui; 1984 Jan; 33(1):43-9. PubMed ID: 6371283
    [No Abstract]   [Full Text] [Related]  

  • 6. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations.
    Fish KJ; Sarnquist FH; van Steennis C; Mitchell RS; Hilberman M; Jamieson SW; Linet OI; Miller DC
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editor's Note: Expression of transforming growth factor beta 1 in lung tissue during cardiopulmonary bypass-induced lung injury in dogs by Wang et al. (epub ahead of print).
    Heinemann MK
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):457. PubMed ID: 23918702
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of intestinal microvascular permeability associated with cardiopulmonary bypass.
    Cox CS; Allen SJ; Brennan M
    J Surg Res; 1999 May; 83(1):19-26. PubMed ID: 10210637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of platelet lysis, platelet consumption on oxygenator, and stabilization of platelet membrane with prostacyclin and ibuprofen during cardiopulmonary bypass surgery in dogs.
    Dewanjee MK; Vogel SR; Peterson KA; Lim MF; Kaye MP
    Trans Am Soc Artif Intern Organs; 1981; 27():197-202. PubMed ID: 7036497
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful four-hour heart-lung preservation with core-cooling on cardiopulmonary bypass: a simplified model that assesses preservation.
    Kontos GJ; Adachi H; Borkon AM; Cameron DE; Baumgartner WA; Hall TS; Hutchins G; Brawn J; Reitz BA
    J Heart Transplant; 1987; 6(2):106-11. PubMed ID: 3114445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of methylprednisolone, ibuprofen, or prostacyclin to reduce HCl-induced pulmonary albumin leak in dogs.
    Buchman SR; Sugerman HJ; Tatum JL; Wright TP; Blocher CR; Hirsch JI
    Surgery; 1984 Aug; 96(2):163-70. PubMed ID: 6379955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotension induced by prostacyclin treatment during cardiopulmonary bypass does not increase the risk of cerebral complications.
    Arén C; Blomstrand C; Wikkelsö C; Rådegran K
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):748-53. PubMed ID: 6208432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokine levels in patients undergoing cardiopulmonary bypass. Does lung reperfusion influence the release of cytokines?
    Kawahito K; Kawakami M; Fujiwara T; Murata S; Yamaguchi A; Mizuhara A; Adachi H; Ino T
    ASAIO J; 1995; 41(3):M775-8. PubMed ID: 8573912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans.
    Faymonville ME; Deby-Dupont G; Larbuisson R; Deby C; Bodson L; Limet R; Lamy M
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):858-66. PubMed ID: 3520158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
    Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
    Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention by a stable prostacyclin analogue, 7-oxoprostaglandin I2 of the platelet loss during experimental cardiopulmonary bypass.
    Juhász-Nagy S; Kékesi V; Sótonyi P; Moravcsik G; Kovács G
    Acta Chir Hung; 1988; 29(3):251-61. PubMed ID: 3071058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatosensory evoked potentials and cerebral metabolism during cardiopulmonary bypass with special reference to hypotension induced by prostacyclin infusion.
    Arén C; Badr G; Feddersen K; Rådegran K
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):73-9. PubMed ID: 3925243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.
    Vane JR
    J Endocrinol; 1982 Nov; 95(2):3P-43P. PubMed ID: 6816886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.